Chapter 4. Legal and Professional Issues in Prescribing

Chapter 4. Legal and Professional Issues in Prescribing

Complete Chapter Questions With Answers

Sample Questions Are Posted Below

Multiple Choice

Identify the choice that best completes the statement or answers the question.

____ 1. The U.S. Food and Drug Administration regulates:

1.	Prescribing of drugs by MDs and NPs
2.	The official labeling for all prescription and over-the-counter drugs
3.	Off-label recommendations for prescribing
4.	Pharmaceutical educational offerings

____ 2. The U.S. Food and Drug Administration approval is required for:

1.	Medical devices, including artificial joints
2.	Over-the-counter vitamins
3.	Herbal products, such as St John’s wort
4.	Dietary supplements, such as Ensure

____ 3. An Investigational New Drug is filed with the U.S. Food and Drug Administration:

1.	When the manufacturer has completed phase III trials
2.	When a new drug is discovered
3.	Prior to animal testing of any new drug entity
4.	Prior to human testing of any new drug entity

____ 4. Phase IV clinical trials in the United States are also known as:

1.	Human bioavailability trials
2.	Postmarketing research
3.	Human safety and efficacy studies
4.	The last stage of animal trials before the human trials begin

Answer Section

MULTIPLE CHOICE

Additional information